Hindustan Bio Sciences shows positive financial performance in Q1 FY25
Hindustan Bio Sciences, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending June 2024. The company has shown a positive performance in this quarter, with its score improving from 3 to 7 in the last 3 months.
One of the key factors contributing to this improvement is the company’s operating profit (PBDIT) which has been the highest in the last five quarters at Rs 0.07 crore. This indicates a positive trend in the near term for the company’s operating profit. Similarly, the profit before tax less other income (PBT) has also been the highest in the last five quarters at Rs 0.07 crore, showing a positive trend in the near term.
The company’s profit after tax (PAT) has also seen a significant increase, with the highest in the last five quarters at Rs 0.08 crore. This indicates a positive trend in the near term for the company’s profitability. Additionally, the earnings per share (EPS) have also been the highest in the last five quarters at Rs 0.08, showing an increase in profitability and creating higher earnings for shareholders.
Based on these financial results, MarketsMOJO has given a ‘Strong Sell’ call for Hindustan Bio Sciences’ stock. This is a neutral and informative assessment of the company’s performance and does not involve any future potential, investor interest, or expert opinions. The company’s positive financial performance in the quarter ending June 2024 is a reflection of its efforts and strategies, and investors can make their own informed decisions based on these facts.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
